Background: Angiotensine converting enzyme inhibitors (ACE-I) are commonly used drugs for treatment of hypertension and heart failure. Cough is most common side effect occurring in 0.7-35% according to various reports. Objective: To estimate the incidence of ACE-I induced cough in IRAQI patients. Method: 2800 Iraqi patients using different ACE-I drugs (captopril, Enalpril, Lisinipril and Ramipril) visiting hypertension and Out-patient –Clinic at ALKARAMA and AL-ZAHRA teaching hospitals at Wasit Governorate / IRAQ, these patients were interviewed for cough related to ACE-I use , patients having cough were underwent investigations to other causes of cough and re-evaluated 4-weeks after changing their medication. Result: 925 patients have ACE-I induced cough (502 (54.27%) females Vs. 423(45.72%) males) so cough occur in 33% of total patients, more common in females , it occur most frequently with Enalipril users (44.75%) and least in Captopril group (25%). Conclusion: ACE-I induced cough is common and underestimated problem in Iraq , genetics and environmental factors are playing important role in the determination of difference incidence around the world.
IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.
